Provectus Biopharmaceuticals Expands Global Patent Portfolio to India for Cancer Combination Therapy
June 09, 2020 09:00 ET
|
Provectus Biopharmaceuticals Inc.
2020 India patent follows 2018 India patent that protects Provectus’ proprietary API manufacturing processProvectus further expands cancer combination therapy IP protection by filing new USPTO patent...
PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURE
June 19, 2018 09:00 ET
|
Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, June 19, 2018 (GLOBE NEWSWIRE) -- Provectus today announced that the Indian Patent Office (IPO) has granted the Company’s patent application for the synthetic...